STE STERIS plc ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES Best Orthopedic Devices Stocks 2026 →

STERIS (STE) Stock: Buy, Sell, or Hold?

$257.12
+0.18 (+0.07%) ▲
5d: +11.14% 30d: +17.42% 90d: +8.67%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (20%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$210.73 – $234.45
Position: EXTENDED
Forward P/E & Valuation
23.2x FAIR
vs 20.9x historical avg
Wall Street Target
$270.71
+5.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$225.01 / $259.25
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: STE shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When STE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$314.09
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$195.02
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.9x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: STE is currently trading at $257.12, which is considered extended relative to its 30-day fair value range of $210.73 to $234.45. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.2) compared to its historical average (20.9). At these levels, the market is pricing in 3.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, STE is in a uptrend. The price is approaching resistance at $259.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: STE scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $210.73 - $234.45
Company Quality Score 32/100 (SELL)
Volume Confirmation HIGH
Confidence Score 20.0%

Trading Range & Key Levels

30-Day Trading Range $210.73 - $234.45
Current vs Trading Range EXTENDED
Support Level $225.01
Resistance Level $259.25
Current Trend Uptrend
Technical data as of Nov 10, 2026

Protect Your Profits

STE is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range (+9.7% above its trading range)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($270.71)
  • NEUTRAL: Market pricing in 3.5% annual earnings growth - fairly valued
  • WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 23.21
Wall Street Target $270.71 (+5.3%)
Revenue Growth (YoY) 8.8%
Earnings Growth (YoY) 12.9%
Profit Margin 13.4%
Valuation Premium vs History +3.5% premium
PE vs Historical 23.2 vs 20.9 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +3.5% (market-implied from PE analysis)
1-Year Target $266.12 (+4%)
2-Year Target $275.43 (+7%)
3-Year Target $285.07 (+11%)
3-Yr Target (if PE normalizes) (PE: 23→21) PE COMPRESSION $256.72 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 23.2, Growth: 8.6%) $329.47 (+28%)
Base: (SPY PE: 19.9, Growth: 8.6%) $281.94 (+10%)
Bear: (PE: 16.9, Growth: 8.6%) $239.65 (-7%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 29.91 | Current EPS (TTM): $8.59
Bull Case $364.52 (+42%)
Analyst growth 29.0%, PE expands to 32.9
Base Case $331.38 (+29%)
Market implied 29.0%, PE stable at 29.9
Bear Case $174.72 (-32%)
Severe decline -20.0%, PE contracts to 25.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share STE Analysis

Share this live STE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

Reddit StockTwits X / Twitter
bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (STE)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
May 12, 2026
Daily AI digest
AI Retail Discussion Summary: Bearish sentiment prevails on $STE after Q4 earnings misses, appointment of diagnostics-focused director and reaffirmed dividend do not materially change near term catalysts or risks.
Key Retail Themes: earnings misses board appointment dividend
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:06 AM ET
Data refreshes hourly during market hours. Next update: 9:06 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is STE showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for STE.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
EW
Edwards Lifesciences Corp 		STRONG BUY
30 analysts 		$112 42 HOLD
BSX
Boston Scientific Corp 		BUY
31 analysts 		$50 53 HOLD
SYK
Stryker Corporation 		STRONG BUY
30 analysts 		$340 31 SELL
MDT
Medtronic PLC 		BUY
30 analysts 		$105 35 SELL
PODD
Insulet Corporation 		BUY
26 analysts 		$178 43 HOLD
EW Edwards Lifescien…
42 HOLD
BSX Boston Scientific…
53 HOLD
SYK Stryker Corporati…
31 SELL
MDT Medtronic PLC
35 SELL
PODD Insulet Corporati…
43 HOLD

Advanced STE Option Strategies

Professional options setups generated by AI based on today's STE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive STE Research Pages
STE Technical Chart STE Price Prediction STE Intrinsic Value DCF STE Earnings Date STE Investment Advisor STE Fair Price Analyzer STE Options Chain STE Options Advisor STE Options Analysis STE Competitors
Part B: Tradestie Flagship Market Scanners
Today's Best Signals (STE) Sector Rotation Monitor AI Supply Chain Money Flow Gamma Squeeze (GEX) Scanner Undervalued Stocks Scanner Insider Cluster Buying Reddit & WSB Sentiment Tracker Backtested Stock Scanner
Compare STE with Peers
STE vs TFX
Which one to buy?
STE vs COO
Which one to buy?
STE vs MTD
Which one to buy?
STE vs WST
Which one to buy?
STE vs RMD
Which one to buy?
ZBH vs STE
SMTI vs STE
ISRG vs STE
EW vs STE
ALGN vs STE
PHG vs STE
RMD vs STE
SPAI vs STE
POAI vs STE
WST vs STE
Winner: WST
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals